Skip to main content
logo
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.6830
-0.0512 (-6.97%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Celularity Revenue

In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. Celularity had revenue of $4.10M in the quarter ending December 31, 2025, a decrease of -77.37%.

Revenue (ttm)
$26.55M
Revenue Growth
-51.03%
P/S Ratio
0.74
Revenue / Employee
$230,870
Employees
115
Market Cap
19.77M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.55M-27.67M-51.03%
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Werewolf Therapeutics21.00M
Marker Therapeutics3.55M
Daré Bioscience1.16M
Allarity Therapeutics345.00K
Neuphoria Therapeutics-13.27K
Revenue Rankings

CELU News

More News